---
title: "CMND.US (CMND.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CMND.US/news.md"
symbol: "CMND.US"
name: "CMND.US"
parent: "https://longbridge.com/zh-HK/quote/CMND.US.md"
datetime: "2026-03-14T10:35:27.176Z"
locales:
  - [en](https://longbridge.com/en/quote/CMND.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CMND.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CMND.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/CMND.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/CMND.US/news.md)


# CMND.US (CMND.US) — 相關新聞

### [Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy | CMND Stock News](https://longbridge.com/zh-HK/news/279037260.md)
*2026-03-13T03:45:38.000Z*
> Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy | CMND Stock News

### [U.S. stock market midday update: Clearmind Medicine down 11.71%, new drug development fails to boost market confidence, valuation risks intensify](https://longbridge.com/zh-HK/news/278932103.md)
*2026-03-12T19:23:49.000Z*
> Clearmind Medicine fell 11.71%; Eli Lilly fell 2.21%, with a trading volume of USD 1.454 billion; Johnson & Johnson rose

### [BUZZ-U.S. STOCKS ON THE MOVE-Nebius, Scienture, Clearmind](https://longbridge.com/zh-HK/news/278750220.md)
*2026-03-11T15:52:40.000Z*
### [NeuroThera and Clearmind Advance Patent for Obesity and Liver Disease Therapy](https://longbridge.com/zh-HK/news/278731642.md)
*2026-03-11T13:24:48.000Z*
> NeuroThera and Clearmind Advance Patent for Obesity and Liver Disease Therapy

### [Pre-market hot trades in US stocks: Clearmind Medicine up 7% in pre-market, with clear capital flow, market sentiment triggers volatility attention](https://longbridge.com/zh-HK/news/278727290.md)
*2026-03-11T13:07:33.000Z*
> Clearmind Medicine pre-market up 7.00%; Kala Pharmaceuticals pre-market up 60.84%; Scienture pre-market up 47.23%; Domo-

### [NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease](https://longbridge.com/zh-HK/news/278712431.md)
*2026-03-11T11:30:02.000Z*
> NeuroThera Labs Inc. has announced the publication of an international patent in collaboration with Clearmind Medicine f

### [Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results  | CMND Stock News](https://longbridge.com/zh-HK/news/278728709.md)
*2026-03-11T05:07:00.000Z*
> Clearmind Medicine Inc. has announced the continuation of participant recruitment for the third cohort of its Phase I/II